Efficacy of sacubitril/valsartan combined with dapagliflozin in treating patients with heart failure and diabetes after an acute myocardial infarction
In diabetic patients suffering from heart failure after an AMI, treatment with sacubitril/valsartan combined with dapagliflozin may effectively control blood glucose levels and improve cardiac functions without increasing adverse reactions, indicating high clinical safety.
Authors
- Jinxia Niu
- Jie Gong (ORCID: https://orcid.org/0000-0003-2518-9439)
- Runjun Li
- Xiuying Tang (ORCID: https://orcid.org/0000-0002-8045-9780)
- Lifang Zhang (ORCID: https://orcid.org/0000-0002-5217-987X)
Institutions
- Qujiang People's Hospital (CN)
- People's Hospital of Yangzhong (CN)
- First Hospital of Qinhuangdao (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2024-11-20
- DOI
- https://doi.org/10.12669/pjms.40.11.8972
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00